October 21, 2010
The common shares of Gemoscan Canada, Inc. have been approved for listing on CNSX. The Company has 17,440,404 shares outstanding with a public float of approximately 7.5 million shares.
Gemoscan owns and markets the Hemocode System, a well-being and lifestyle solution that with a simple blood test that detects and provides solutions for the treatment of food intolerances. The Hemocode System generates customer-specific reports and recipe books which are provided to the customer accompanied by feedback from a health care specialist.
Listing and disclosure documents for Gemoscan Canada, Inc. will be available in the CNSX Listings Disclosure Hall
Trading Date: Friday, October 22, 2010
CUSIP: 36866N 10 6
ISIN: CA 36866N 10 6 9
Applications are being accepted for Market Makers for "GES". If you have any questions or require further information please contact Radhika at (416) 572-2000 X 2435 or E-mail: email@example.com